Squarepoint’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $72.9K | Sell |
221,126
-44,365
| -17% | -$14.6K | ﹤0.01% | 2558 |
|
2025
Q1 | $82.8K | Buy |
+265,491
| New | +$82.8K | ﹤0.01% | 2557 |
|
2024
Q2 | – | Sell |
-68,343
| Closed | -$208K | – | 2846 |
|
2024
Q1 | $208K | Buy |
68,343
+56,962
| +501% | +$174K | ﹤0.01% | 2073 |
|
2023
Q4 | $36.6K | Buy |
+11,381
| New | +$36.6K | ﹤0.01% | 2391 |
|
2023
Q2 | – | Sell |
-11,271
| Closed | -$29.1K | – | 2710 |
|
2023
Q1 | $29.1K | Buy |
+11,271
| New | +$29.1K | ﹤0.01% | 2154 |
|
2022
Q3 | – | Sell |
-10,543
| Closed | -$23K | – | 2392 |
|
2022
Q2 | $23K | Buy |
+10,543
| New | +$23K | ﹤0.01% | 2017 |
|
2021
Q3 | – | Sell |
-37,797
| Closed | -$148K | – | 2609 |
|
2021
Q2 | $148K | Buy |
+37,797
| New | +$148K | ﹤0.01% | 2332 |
|
2021
Q1 | – | Sell |
-70,987
| Closed | -$164K | – | 2923 |
|
2020
Q4 | $164K | Sell |
70,987
-69,731
| -50% | -$161K | ﹤0.01% | 2209 |
|
2020
Q3 | $808K | Buy |
+140,718
| New | +$808K | 0.01% | 1049 |
|
2020
Q2 | – | Sell |
-11,553
| Closed | -$34K | – | 2367 |
|
2020
Q1 | $34K | Sell |
11,553
-14,476
| -56% | -$42.6K | ﹤0.01% | 1742 |
|
2019
Q4 | $108K | Buy |
+26,029
| New | +$108K | ﹤0.01% | 2240 |
|
2018
Q3 | – | Sell |
-14,700
| Closed | -$115K | – | 2151 |
|
2018
Q2 | $115K | Buy |
+14,700
| New | +$115K | ﹤0.01% | 1630 |
|